 Excess N-Myc is associated with a variety of tumors, most notably neuroblastomas where patients with amplification of the N-Myc gene tend to have poor outcomes.MYCN can also be activated in neuroblastoma and other cancers through somatic mutation.N-Myc has been shown to interact with MAX.